Most grade II and grade III gliomas, as well as the secondary glioblastomas that arise from these tumors, possess point mutations that affect the substrate binding site of isocitrate dehydrogenase.
In the case of the enzyme, isocitrate dehydrogenase, the kinetic alterations of many orders of magnitude of the enzyme action are related to changes of a fraction of an angstrom of its amino acid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback